Zobrazeno 1 - 10
of 396
pro vyhledávání: '"D, Seeger"'
Autor:
Rachel P. Ogilvie, J. Bradley Layton, Patricia C. Lloyd, Yixin Jiao, Djeneba Audrey Djibo, Hui Lee Wong, Joann F. Gruber, Ron Parambi, Jie Deng, Michael Miller, Jennifer Song, Lisa B. Weatherby, Lauren Peetluk, An-Chi Lo, Kathryn Matuska, Michael Wernecke, Christine L. Bui, Tainya C. Clarke, Sylvia Cho, Elizabeth J. Bell, Grace Yang, Kandace L. Amend, Richard A. Forshee, Steven A. Anderson, Cheryl N. McMahill-Walraven, Yoganand Chillarige, Mary S. Anthony, John D. Seeger, Azadeh Shoaibi
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background COVID-19 vaccines are authorized for use in children in the United States; real-world assessment of vaccine effectiveness in children is needed. This study’s objective was to estimate the effectiveness of receiving a complete pr
Externí odkaz:
https://doaj.org/article/a71040a255aa47ef99a2668dec27e3e6
Autor:
J. Bradley Layton, Lauren Peetluk, Hui Lee Wong, Yixin Jiao, Djeneba Audrey Djibo, Christine Bui, Patricia C. Lloyd, Joann F. Gruber, Michael Miller, Rachel P. Ogilvie, Jie Deng, Ron Parambi, Jennifer Song, Lisa B. Weatherby, An-Chi Lo, Kathryn Matuska, Michael Wernecke, Tainya C. Clarke, Sylvia Cho, Elizabeth J. Bell, John D. Seeger, Grace Wenya Yang, Dóra Illei, Richard A. Forshee, Steven A. Anderson, Cheryl N. McMahill-Walraven, Yoganand Chillarige, Kandace L. Amend, Mary S. Anthony, Azadeh Shoaibi
Publikováno v:
Vaccine: X, Vol 16, Iss , Pp 100447- (2024)
Background: Monovalent booster/additional doses of COVID-19 vaccines were first authorized in August 2021 in the United States. We evaluated the real-world effectiveness of receipt of a monovalent booster/additional dose of COVID-19 vaccine compared
Externí odkaz:
https://doaj.org/article/24a425573ed6479eb8e9ad2ca557699a
Autor:
Andrea K. Chomistek, Caihua Liang, Michael C. Doherty, C. Robin Clifford, Rachel P. Ogilvie, Robert V. Gately, Jennifer N. Song, Cheryl Enger, Nancy D. Lin, Florence T. Wang, John D. Seeger
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background There are limited data on risk factors for serious outcomes and death from COVID-19 among patients representative of the U.S. population. The objective of this study was to determine risk factors for critical care, ventilation, an
Externí odkaz:
https://doaj.org/article/351b4730558741a3979d9fb4610c4d89
Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study
Autor:
Kandace L. Amend, Bruce Turnbull, Li Zhou, Morgan A. Marks, Christine Velicer, Patricia Saddier, John D. Seeger
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
The 4-valent human papillomavirus (HPV) vaccine (4vHPV vaccine), Gardasil®, is indicated for the prevention of several HPV-related diseases. The objective was to assess the safety of 4vHPV vaccine administered to males as part of routine care. The s
Externí odkaz:
https://doaj.org/article/f2370b3a92844b73ade4a3aeff520f49
Autor:
Angel B Algarin, Gabriela N Plazarte, Kaitlin R Sovich, Stella D Seeger, Yancheng Li, Ronald A Cohen, Catherine W Striley, Bruce A Goldberger, Yan Wang, Charurut Somboonwit, Gladys E Ibañez, Emma C Spencer, Robert L Cook
Publikováno v:
JMIR Research Protocols, Vol 11, Iss 8, p e37153 (2022)
BackgroundMarijuana use is common in persons with HIV, but there is limited evidence of its relationship with potential health benefits or harms. ObjectiveThe Marijuana Associated Planning and Long-term Effects (MAPLE) study was designed to evaluate
Externí odkaz:
https://doaj.org/article/d73ac9fde90b4238b5edd5f5b2023eef
Autor:
Katherine C. Hughes, Timothy A. Herring, Jennifer N. Song, Robert V. Gately, Lindsey M. Przybyl, Rachel P. Ogilvie, Keiko Simon, Prakash K. Bhuyan, Maria Kyrgiou, John D. Seeger
Publikováno v:
Journal of Lower Genital Tract Disease. 27:105-112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf919e73b0b0fbd069bcc8d38e1af864
https://doi.org/10.1097/lgt.0000000000000719
https://doi.org/10.1097/lgt.0000000000000719
Autor:
Andrea K. Chomistek, Kelesitse Phiri, Michael C. Doherty, Jenna F. Calderbank, Stephanie E. Chiuve, Brenda Hinman McIlroy, Michael C. Snabes, Cheryl Enger, John D. Seeger
Publikováno v:
Drug Safety. 46:209-222
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36266a9d0e5b874003e36741cc78dd93
https://doi.org/10.1007/s40264-022-01261-5
https://doi.org/10.1007/s40264-022-01261-5
Autor:
Keran, Moll, Bradley, Lufkin, Kathryn R, Fingar, Cindy, Ke Zhou, Ellen, Tworkoski, Chianti, Shi, Shayan, Hobbi, Mao, Hu, Minya, Sheng, Jillian, McCarty, Shanlai, Shangguan, Timothy, Burrell, Yoganand, Chillarige, Jeff, Beers, Patrick, Saunders-Hastings, Stella, Muthuri, Kathryn, Edwards, Steven, Black, Jeff, Kelman, Christian, Reich, Kandace L, Amend, Djeneba Audrey, Djibo, Daniel, Beachler, Rachel P, Ogilvie, Alex, Secora, Cheryl N, McMahill-Walraven, John D, Seeger, Patricia, Lloyd, Deborah, Thompson, Rositsa, Dimova, Thomas, MaCurdy, Joyce, Obidi, Steve, Anderson, Richard, Forshee, Hui-Lee, Wong, Azadeh, Shoaibi
Publikováno v:
Vaccine. 41:333-353
The U.S. Food and Drug Administration (FDA) Biologics Effectiveness and Safety (BEST) Initiative conducts active surveillance of adverse events of special interest (AESI) after COVID-19 vaccination. Historical incidence rates (IRs) of AESI are compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8aef7bb5020f78a013080315d163c66
https://doi.org/10.1016/j.vaccine.2022.11.003
https://doi.org/10.1016/j.vaccine.2022.11.003
Autor:
Sigal Kaplan, Monica L. Bertoia, Amir Lass, Florence T. Wang, Alison Evans, Sandeep Dhanda, Debabrata Roy, John D. Seeger
Publikováno v:
Pharmacoepidemiology and Drug Safety. 32:78-83
As part of the European risk management plan of a 91-day extended levonorgestrel-containing combined oral contraceptive (COCWe conducted a retrospective cohort study in new users of 91-day COCThe 91-day and 28-day COCSmall differences were observed f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73957df42716761c52d1a797a5843785
https://doi.org/10.1002/pds.5497
https://doi.org/10.1002/pds.5497
Autor:
Mao Hu, Hui Lee Wong, Yuhui Feng, Patricia C. Lloyd, Elizabeth R. Smith, Kandace L. Amend, Annemarie Kline, Daniel C. Beachler, Joann F. Gruber, Mahasweta Mitra, John D. Seeger, Charlalynn Harris, Alex Secora, Joyce Obidi, Jing Wang, Jennifer Song, Cheryl N. McMahill-Walraven, Christian Reich, Rowan McEvoy, Rose Do, Yoganand Chillarige, Robin Clifford, Danielle D. Cooper, Azadeh Shoaibi, Richard Forshee, Steven A. Anderson
Publikováno v:
JAMA Pediatrics.
ImportanceActive monitoring of health outcomes after COVID-19 vaccination offers early detection of rare outcomes that may not be identified in prelicensure trials.ObjectiveTo conduct near–real-time monitoring of health outcomes following BNT162b2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47c7500b602b68fab78767c74766d3be
https://doi.org/10.1001/jamapediatrics.2023.1440
https://doi.org/10.1001/jamapediatrics.2023.1440